Eduardo Lobo Pancreatic and Biliopancreatic Surgery Unit Hospital Universitario Ramón y Cajal Biography Publications Institution JoVE Articles Eduardo Lobo has not added a biography. If you are Eduardo Lobo and would like to personalize this page please email our Author Liaison for assistance. Publications Assesment, Impact and Management of Moderate and Severe Duodenopancreatectomy Complications Cirugia Espanola. May, 2022 | Pubmed ID: 35472531 Leiomyosarcoma of the Right Gonadal Vein Cirugia Espanola. Dec, 2021 | Pubmed ID: 34764061 Assesment, Impact and Management of Moderate and Severe Duodenopancreatectomy Complications Cirugia Espanola. May, 2021 | Pubmed ID: 34082893 Anterograde Intraoperative Pancreatic Stent Placement and Round Ligament Patch to Prevent Pancreatic Fistula After Distal Pancreatectomy Cirugia Espanola. May, 2021 | Pubmed ID: 33388136 Leiomyosarcoma of the Right Gonadal Vein Cirugia Espanola. Oct, 2020 | Pubmed ID: 33143848 Relevance of Positive Resection Margins in Ductal Pancreatic Adenocarcinoma and Prognostic Factors Cirugia Espanola. Feb, 2020 | Pubmed ID: 31395275 The Long-term Recurrence Rate and Survival of Obstructive Left-sided Colon Cancer Patients: a Stent As a Bridge to Surgery Revista Espanola De Enfermedades Digestivas. Nov, 2018 | Pubmed ID: 30071736 Duodenal Fistula After Gastrectomy: Retrospective Study of 13 New Cases Revista Espanola De Enfermedades Digestivas. Jan, 2016 | Pubmed ID: 26765231 Comparative Study Between Open and Minimally Invasive Approach in the Surgical Management of Esophageal Leiomyoma Revista Espanola De Enfermedades Digestivas. Jan, 2016 | Pubmed ID: 26765229 Circulating Tumor Cells (Ctc) and Kras Mutant Circulating Free Dna (cfdna) Detection in Peripheral Blood As Biomarkers in Patients Diagnosed with Exocrine Pancreatic Cancer BMC Cancer. Oct, 2015 | Pubmed ID: 26498594 Sacral Chordoma: Management of a Rare Disease in a Tertiary Hospital Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Apr, 2013 | Pubmed ID: 22865326 Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 암 연구학
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 암 연구학